|
Total
|
150 (100)
|
|
Age in yrs
|
Median 11 yrs, Range [5.1–16.3 yrs]
|
|
5.1–10.9 yrs
|
73 (48.7)
|
|
≥11 yrs
|
77 (51.3)
|
|
Tumor size
| |
|
< 2 cm
|
53 (36.5)
|
|
≥ 2 cm
|
92 (63.5)
|
|
Histological type
| |
|
Squamous cell carcinoma
|
6 (4)
|
|
Simple carcinoma: Anaplastic
|
6 (4)
|
|
Complex carcinoma
|
11 (7.3)
|
|
Simple carcinoma: Solid
|
40 (26.7)
|
|
Simple carcinoma: Tubulopapillary
|
87 (58)
|
|
Histological grade (Elston & Ellis)
| |
|
Grade I
|
19 (12.6)
|
|
Grade II
|
58 (38.7)
|
|
Grade III
|
73 (48.7)
|
|
Lymph node status
| |
|
Positive (N1)
|
32 (21.3)
|
|
Negative (N0)
|
19 (12.7)
|
|
Unknown (NX)
|
99 (66)
|
|
ER expression
| |
|
Positive (≥ 10 %)
|
35 (23.3)
|
|
Negative (< 10 %)
|
115 (76.7)
|
|
PR expression
| |
|
Positive (≥ 10 %)
|
20 (13.3)
|
|
Negative (< 10 %)
|
130 (86.7)
|
|
HER2
| |
|
Score 0
|
85 (56.7)
|
|
Score 1+
|
50 (33.3)
|
|
Score 2+
|
15 (10)
|
|
Score 3+
|
0
|
|
CK5/6
| |
|
Positive (≥ 10 %)
|
89 (59.3)
|
|
Negative (< 10 %)
|
61 (40.7)
|
|
EGFR
| |
|
Positive (≥ 10 %)
|
72 (48)
|
|
Negative (< 10 %)
|
78 (52)
|
|
Immunophenotype
| |
|
Luminal-A
|
17 (11.3)
|
|
Luminal-B
|
30 (20)
|
|
Triple-negative basal like
|
70 (46.7)
|
|
Triple-negative non basal like
|
33 (22)
|
|
IGF1R expression
| |
|
Score 0–1+
|
34 (22.7)
|
|
Score 2+
|
54 (36)
|
|
Score 3+
|
62 (41.3)
|
|
Survival Time in days
|
Median 331 days, Range [2–2608]
|
